RosnerM.H., and BoltonW.K.Target Hemoglobin; in Nissenson AR and Fine RN: Handobook of dialysis therapy. 4a edizione, Saunders Elsevier, 2008: 845–54.
2.
VolkovaN., and ArabL.Evidence-based systematic literature review of haemoglobin/hematocrit and all-cause mortality in dialysis patients.Am J Kidney Dis2006; 47: 24–36.
3.
BesarabA.. The effects of normal as compared with low hematocrit values in patients with cardiac disease who receiving hemodialysis and epoetin.N Engl J Med1998; 339: 584–90.
4.
LocatelliF., PisoniR.L.. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).Nephrol Dial Transplant2004; 19: 121–32.
5.
RegidorD.L.. Association between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients.J Am Soc Nephrol2006; 17: 1181–91.
6.
SchmidtR.J., and BesarabA.Anemia in patients with end-stage renal disease; in NissensonA.R., and FineR.N.: Handobook of dialysis therapy. 4a edizione, Saunders Elsevier; 2008: 761–9.
7.
StenvinkelP., and BárányP.Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure: links to inflammation and oxidative stress.Nephrol Dial Transplant2002; 17(Suppl 5): S32–7.
8.
CanaudB., LevesqueR.. On-Line hemodiafiltration as routine treatment of en-stage renal failure: why pre- or mixed dilution mode is necessary in on-line hemodiafiltration today?Blood Purif2004; 22(Suppl 2): S40–8.
9.
KrietesD.H., CollinsG.. Mid-dilution on-line haemodiafiltration in a standard dialyser configuration.Nephrol Dial Transplant2005; 20: 155–60.
10.
PedriniL.A., DeC.. Mixed predilution and postdilution online hemodiafiltration compared with the traditional infusion modes.Kidney Int2000; 58: 2155–65.
11.
PedriniL.A., DeC.. On-line mixed hemodiafiltration with a feedback for ultrafiltration control: effect on middle-molecule removal.Kidney Int2003; 64: 1505–13.
12.
PizzarelliF., TettaC.. Double-chamber on-line hemodiafiltration: a novel technique with intra-treatment monitoring of dialysate ultrafilter integrity.Blood Purif2000; 18: 237–41.
13.
PanichiV., RizzaG.M., PaolettiS.. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.Nephrol Dial Transplant2008; 23: 2337–43.
14.
AhrenholzP., WinklerR.E.. On-line hemodiafiltration with pre- and postdilution: a comparison of efficacy.Int J Artif Organs1997; 20: 81–90.
WizemannV., KulzM.. Efficacy of haemodiafiltration.Nephrol Dial Transplant2001; 16(Suppl 4): S27–30.
18.
DingF., AhrenholzP.. On-line hemodiafiltration versus acetate free-biofiltration: a prospective crossover study.Artif Organs2002; 26: 169–80.
19.
MinutoloR., BellizziV.. Postdialytic rebound of serum phosphorus: pathogenetic and clinical insights.J Am Soc Nephrol2002; 13: 1046–54.
20.
BonforteG., GrilloP.Improvement of anemia in hemodialysis patients treated by hemodiafiltration with high-volume on-line-prepaared substitution fluid.Blood Purif2002; 20: 357–63.
21.
GonellaM., PrtaesiG.. Improvement of anemia in patients on chronic dialysis treated by hemodiafiltration.Blood Purif1989; 7: 186–91.
22.
BoumanC.S., van OldenR.W.. Cytokine filtration and adsorption during pre-and postdilution hemofiltration in four different membranes.Blood Purif1998; 16: 261–8.
23.
GoldfarbS., GolperrT.A.Proinflammatory cytokines and hemofiltration membranes.J Am Soc Nephrol1994; 5: 228–32.